Bayer Korea Ltd., local subsidiary of German pharmaceutical company Bayer AG, announced on Friday that it will resume sales of 500-milligram aspirin tablets in South Korea, 20 months after it voluntarily recalled the anti-inflammatory and fever-reducing drug in 2016.
Bayer Korea said that its 500-milligram aspirin tablets will return to the shelves in Korea this year. The company voluntarily recalled them in December 2016 after it found that the dissolution rate of some of its aspirin tablets produced at its manufacturing facility in Indonesia did not meet the safety standard. Dissolution rate refers to the rate at which a drug’s active ingredients dissolve in the body.
An unnamed official from Bayer Korea said that resupply of 500-milligram aspirin tablets has been delayed than the initial plan as the manufacturing facility has been relocated from Indonesia to Germany, and there has been additional facility investment and preparation procedure for safety containers and packaging to meet standards. The official expected the supply to stabilize by the end of the year.
There are two types of Bayer’s aspirin drug - 100-milligram and 500-milligram. The 100-milligram aspirin drug contains the same amount and components as the 100-milligram aspirin protect pills taken to prevent cardiovascular problems.
The more commonly sought 500-milligram aspirin tablets are taken to reduce fever and pain.
Bayer - headquartered in Leverkusen in Germany - made inroads into the Korean market for the first time in 1955 with its crop protection business. The company has expanded business areas to include not only medicines but also healthcare, animal medicine and medical supplies, and seeds.
By Kim Hye-soon and Lee Eun-joo
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]